Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The Avenir Award Program for Research on Substance Abuse and HIV/AIDS is dedicated to supporting early stage investigators proposing innovative studies at the intersection of substance abuse and HIV/AIDS, in line with NIH HIV/AIDS Research Priorities. The program encourages creative and original research with the potential to significantly impact substance-using populations at risk for or living with HIV/AIDS. It aims to fund projects that could lead to a reduction in HIV incidence, enhancements in therapies for HIV, a decrease in the impact of comorbid conditions, and, ultimately, the eradication of HIV. The connection with drug abuse should be clearly articulated in the proposals.

    Eligibility

    Organization's Location
    cillum duis, ut duis, occaecat qui, elit dolor, mollit aliquip, sunt anim
    Program Location
    velit commodo ex officia commodo duis occaecat ad consectetur sit
    Organization Type
    up to 1.5M

    Submission

    Schedule
    Step 1: culpa labore consectetur
    Application deadline
    Mar 18, 2025
    Step 2: adipisicing velit (elit eu)

    Similar grants

    5 of 5 free pages viewed this month
    Sign up to view this and 11K+ more grant opportunities
    Already have an account?Log in